Who Owns Synnovia Company?

Who Owns Synnovia?

Understanding a company's ownership is key to grasping its strategy and accountability. Synnovia transitioned to private ownership in October 2019 via an acquisition vehicle backed by Camelot Capital Partners LLC and Synnovia's management.

This privatization marked a significant shift in Synnovia's governance and operational direction, moving away from its public listing on the AIM market.

Synnovia Limited, established in 2002, specializes in plastic solutions, including compounding, masterbatch production, and recycling. The company operates globally with factories in the UK and Thailand, and sales offices in the USA, Japan, India, and China. Founded by Faisal Rahmatallah and Arun Nagwaney, Synnovia focuses on proprietary products for niche markets. As of March 31, 2024, Synnovia reported a turnover of £75.6 million and employed over 250 people directly, with a total of 614 employees across its operations. The company's growth strategy involves both organic expansion and strategic acquisitions, aiming to enhance shareholder value. Their product offerings include solutions like those found in the Synnovia BCG Matrix.

Synnovia Limited, initially incorporated as Plastics Capital Trading PLC on October 2, 2007, was founded by Faisal Rahmatallah and Arun Nagwaney in December 2002. Faisal Rahmatallah continues to hold the position of Chairman, guiding the company's strategic direction. While precise initial ownership percentages are not publicly disclosed, their entrepreneurial efforts laid the foundation for Synnovia's subsequent expansion. This article delves into the early ownership and strategic acquisitions that shaped the company.

Founding Vision

Faisal Rahmatallah and Arun Nagwaney established Synnovia in December 2002. Their vision was to build a company focused on niche manufacturing sectors.

Corporate Evolution

The company underwent several name changes, starting as Plastics Capital Trading PLC, then Plastics Capital PLC, before becoming Synnovia PLC. This evolution reflects its growth and strategic repositioning.

Early Investment Strategy

Synnovia's early growth was significantly driven by strategic acquisitions. This approach allowed for rapid market penetration and consolidation of expertise.

Acquisition of Bell Plastics

In January 2003, Synnovia acquired a 15% stake in Bell Plastics, a specialist hose mandrel manufacturer. This investment secured effective management control.

Expansion into Creasing Matrix

The company acquired Trimplex, a creasing matrix specialist, and Channel Matrix in August 2007. These acquisitions bolstered its position in this niche market.

Diversification into Ball Bearings

In November 2005, Synnovia acquired 100% of BNL, a company focused on designing and manufacturing high-quality ball bearing solutions. This marked a diversification of its product portfolio.

Founders and Early Ownership Dynamics

The founders, Faisal Rahmatallah and Arun Nagwaney, initiated Synnovia's journey with a clear strategy of consolidating niche manufacturing businesses. Their early acquisitions, such as the 15% stake in Bell Plastics in January 2003 and the full acquisition of BNL in November 2005, demonstrate a deliberate approach to building market share and expertise. This period of strategic investment laid the groundwork for the company's future growth, as detailed in the Brief History of Synnovia. The focus on specialized sectors like hose mandrels, creasing matrices, and ball bearings highlights a targeted expansion strategy.

• Founders: Faisal Rahmatallah and Arun Nagwaney
• Incorporation: October 2, 2007 (as Plastics Capital Trading PLC)
• Establishment: December 2002
• Key Early Acquisition: Bell Plastics (15% stake, January 2003)
• Strategic Focus: Niche manufacturing sectors

Synnovia's ownership journey began with its public listing on London's AIM market in December 2007. A pivotal shift occurred in October 2019 when the company was taken private in a £48.8 million deal, fundamentally altering its ownership structure and operational environment.

Following its privatization in October 2019, Synnovia transitioned to a privately held entity, backed by private equity. The primary investor and controlling stakeholder is Camelot Capital Partners LLC, operating through its acquisition vehicle, BPF1 Limited. This move was intended to provide greater flexibility for growth and acquisitions, away from the public market's demands. As of March 31, 2024, Synnovia reported a turnover of £75.6 million, with adjusted EBITDA at £2.26 million. The company's financial strategy has included reducing net debt by £3.6 million to £11.0 million, achieved by replacing third-party debt with shareholder loans, a move designed to mitigate business risk. These strategic adjustments, including cost base realignment and pricing structure modifications, were completed in FY2024 to enhance profitability, reflecting the focused approach enabled by private ownership. Understanding the Marketing Strategy of Synnovia provides further context on how these ownership changes influence business operations.

Synnovia's Ownership Landscape

Synnovia is currently a privately held company, with its ownership structure primarily determined by its private equity backing.

• Primary Investor: Camelot Capital Partners LLC
• Acquisition Vehicle: BPF1 Limited
• Management Team: Involved in ownership alongside primary investor
• Public Status: No longer publicly traded on AIM

Synnovia Limited's board of directors includes key figures representing its major shareholders and management. As of August 2025, active directors include Chairman Mr. Faisal John Rahmatallah, appointed in October 2007, Mr. William Jack Barker, appointed in July 2020, and Mr. Anthony Green, appointed in February 2024. Mrs. Georgina Stephanie Clark, Group Finance Director, joined the board in February 2022, and Mrs. Anna Whitehead serves as Group Legal Director and Corporate Secretary.

Following its acquisition by BPF1 Limited, which is owned by Camelot Capital Partners LLC and the management team, Synnovia operates as a privately held entity. This privatization means voting power is largely concentrated with Camelot Capital and the management team. Mr. William Jack Barker's association with Barker Partnership LP, a significant prior stakeholder, further links to Camelot Capital's influence. This ownership structure allows for strategic decisions to be implemented without the direct oversight of public shareholders, with the board and shareholders expressing confidence in future profitability improvements post-restructuring.

Synnovia's Corporate Governance and Ownership Structure

Understanding who owns Synnovia and how its board operates is crucial for grasping its strategic direction. The company's transition to private ownership has consolidated voting power.

• Synnovia is now a privately held company.
• Camelot Capital Partners LLC and the management team are the primary owners.
• Voting power is concentrated with these majority shareholders.
• The board composition reflects these ownership interests.
• This structure aims to facilitate strategic restructuring and profitability improvements.

Since its privatization in October 2019, Synnovia has been under the ownership of private equity firm Camelot Capital Partners LLC. This shift to private ownership has allowed the company to focus on internal restructuring and operational optimization over the past 3-5 years.

In the year ended March 31, 2024, Synnovia reported a turnover of £75.6 million, a decrease from £89.5 million in the previous year. Despite this 15.5% reduction in turnover, attributed to a global economic slowdown and the UK energy crisis between October 2022 and August 2023, the company's profitability has shown improvement. Adjusted EBITDA increased to £2.26 million in FY2024 from £2.15 million in FY2023, reflecting successful restructuring efforts. The company also reduced its third-party net debt by £3.6 million to £11.0 million by replacing external debt with shareholder loans, thereby lowering business risk.

Operational Efficiency Improvements

Synnovia has improved its profitability conversion, with adjusted EBITDA rising to £2.26 million in FY2024. This demonstrates the effectiveness of internal restructuring and cost base realignments.

Financial Risk Management

Third-party net debt was reduced by £3.6 million to £11.0 million by March 31, 2024. This was achieved by substituting third-party debt with shareholder loans to mitigate business risk.

Environmental and Innovation Focus

The company achieved carbon neutral status for the year ending March 31, 2024. Synnovia is also actively innovating in plastic solutions, aiming to increase recycled content in film packaging and reduce PVC scrap.

Future Profitability Outlook

Synnovia's board and shareholders are optimistic about future profitability improvements. They anticipate significant gains as sales volumes are expected to recover to normal levels post-FY2024.